p.3 Cytology (general) | pathos223project

course 1
program3. Cytology (general) 86 cases

cyto-1-Cx_cyto-gyne (1-24)_uterine cervix_45F_Pap_NILM: squamous metaplasia

cyto-2-Cx_cyto-gyne (1-24)_uterine cervix_60'sF_Pap_NILM: senile colpitis

cyto-3-Cx_cyto-gyne (1-24)_uterine cervix_40'sF_Pap_NILM: reactive irradiation change

cyto-4-Cx_cyto-gyne (1-24)_uterine cervix_40'sF_Pap_NILM: reactive irradiation change

cyto-5-Cx_cyto-gyne (1-24)_uterine cervix_28F_Pap (LBC)_NILM: Gardnerella infection

cyto-6-Cx_cyto-gyne (1-24)_uterine cervix_23F_Pap (LBC)_NILM: herpes simplex virus infection

cyto-7-Cx_cyto-gyne (1-24)_uterine cervix_30'sF_Pap_NILM: Trichomonas vaginalis infection

cyto-8-Cx_cyto-gyne (1-24)_uterine cervix_21F_Pap_NILM: Trichomonas vaginalis infection

cyto-9-Cx_cyto-gyne (1-24)_uterine cervix_41F_Pap (LBC)_LSIL: mild dysplasia

cyto-10-Cx_cyto-gyne (1-24)_uterine cervix_45F_Pap (LBC)_LSIL: mild dysplasia

cyto-12-Cx_cyto-gyne (1-24)_uterine cervix_35F_Pap (LBC)_HSIL: moderate dysplasia

cyto-13-Cx_cyto-gyne (1-24)_uterine cervix_44F_Pap (LBC)_HSIL: moderate dysplasia

cyto-14-Cx_cyto-gyne (1-24)_uterine cervix_86F_Pap (LBC)_HSIL: severe dysplasia

cyto-15-Cx_cyto-gyne (1-24)_uterine cervix_30F_Pap (LBC)_HSIL: severe dysplasia

cyto-16-Cx_cyto-gyne (1-24)_uterine cervix_40F_Pap_HSIL: severe dysplasia

cyto-17-Cx_cyto-gyne (1-24)_uterine cervix_40F_Pap (LBC)_HSIL: CIS

cyto-18-Cx_cyto-gyne (1-24)_uterine cervix_44F_Pap (LBC)_SCC (squamous cell carcinoma)

cyto-20-Cx_cyto-gyne (1-24)_uterine cervix_54F_Pap_SCC (squamous cell carcinoma)

cyto-23-Em_cyto-gyne (1-24)_endometrium_37F_Pap_secretory phase endometrium

cyto-24-Em_cyto-gyne (1-24)_endometrium_63F_Pap_endometrioid adenocarcinoma

cyto-25-sputum_cyto-lung (25-31)_sputum_31F_Pap_adenocarcinoma

cyto-26-sputum_cyto-lung (25-31)_sputum_73M_Pap_adenocarcinoma

cyto-27-sputum_cyto-lung (25-31)_sputum_77M_Pap_squamous cell carcinoma

cyto-28-sputum_cyto-lung (25-31)_sputum_81M_Pap_squamous cell carcinoma

cyto-29-sputum_cyto-lung (25-31)_sputum_79M_Pap (LBC)_small cell carcinoma

cyto-30-sputum_cyto-lung (25-31)_sputum_79F_Pap_small cell carcinoma

cyto-31-sputum_cyto-lung (25-31)_bronchial lavage_61F_Pap_metastatic adenocarcinoma (breast cancer)

cyto-32-breast_cyto-FNA (32-35)_breast_82F_Pap_ductal carcinoma

cyto-34-thyroid_cyto-FNA (32-35)_thyroid_53F_Pap_papillary carcinoma

cyto-35-1-thyroid_cyto-FNA (32-35)_thyroid_41F_Pap_papillary carcinoma-1

cyto-35-2-thyroid_cyto-FNA (32-35)_thyroid_41F_Giemsa_papillary carcinoma-2

cyto-36-1-PE_cyto-effusion (36-55)_pleural effusion_60'sM_Pap_reactive mesothelial cells-1

cyto-36-2-PE_cyto-effusion (36-55)_pleural effusion_60'sM_PAS_reactive mesothelial cells-2

cyto-37-1-PE_cyto-effusion (36-55)_pleural effusion_60'sM_Pap_reactive mesothelial cells-1

cyto-37-2-PE_cyto-effusion (36-55)_pleural effusion_60'sM_Giemsa_reactive mesothelial cells-2

cyto-38-1-PE_cyto-effusion (36-55)_pleural effusion_50'sM_Pap_malignant mesothelioma-1

cyto-38-2-PE_cyto-effusion (36-55)_pleural effusion_50'sM_Giemsa_malignant mesothelioma-2

cyto-38-3-PE_cyto-effusion (36-55)_pleural effusion_50'sM_PAS_malignant mesothelioma-3

cyto-39-PE_cyto-effusion (36-55)_pleural effusion_55M_Pap_malignant mesothelioma

cyto-40-PE_cyto-effusion (36-55)_pleural effusion_60'sM_Pap_malignant mesothelioma

cyto-41-1-PE_cyto-effusion (36-55)_pleural effusion_60'sM_Pap_malignant mesothelioma-1

cyto-41-2-PE_cyto-effusion (36-55)_pleural effusion_60'sM_Giemsa_malignant mesothelioma-2

cyto-43-PE_cyto-effusion (36-55)_pleural effusion_66M_Pap_poorly differentiated adenocarcinoma of lung

cyto-44-1-PE_cyto-effusion (36-55)_pleural effusion_50'sM_Pap_poorly differentiated adenocarcinoma of lung-1

cyto-44-2-PE_cyto-effusion (36-55)_pleural effusion_50'sM_Giemsa_poorly differentiated adenocarcinoma of lung-2

cyto-45-PE_cyto-effusion (36-55)_pleural effusion_70'sF_Pap_metastatic adenocarcinoma of lung

cyto-46-PE_cyto-effusion (36-55)_pleural effusion_71M_Pap_metastatic small cell carcinoma

cyto-47-1-PE_cyto-effusion (36-55)_pleural effusion_48F_Pap_metastatic breast carcinoma-1

cyto-47-2-PE_cyto-effusion (36-55)_pleural effusion (cell block)_48F_HE_metastatic breast carcinoma-2

cyto-49-ascites_cyto-effusion (36-55)_ascites_50'sM_Pap_malignant mesothelioma

cyto-50-1-ascites_cyto-effusion (36-55)_ascites_40'sF_Pap_metastatic ovarian carcinoma-1

cyto-51-ascites_cyto-effusion (36-55)_ascites_48F_Pap_metastatic ovarian carcinoma

cyto-52-1-ascites_cyto-effusion (36-55)_ascites_50F_Pap_metastatic ovarian carcinoma-1

cyto-52-2-ascites_cyto-effusion (36-55)_ascites_50F_PAS_metastatic ovarian carcinoma-2

cyto-53-1-ascites_cyto-effusion (36-55)_ascites_70'sF_Pap_metastatic gastric carcinoma-1

cyto-53-2-ascites_cyto-effusion (36-55)_ascites_70'sF_PAS_metastatic gastric carcinoma-2

cyto-54-ascites_cyto-effusion (36-55)_ascites_40'sM_Pap_metastatic pancreas carcinoma

cyto-55-1-ascites_cyto-effusion (36-55)_ascites_80'sF_Pap_invasion of multiple myeloma-1

cyto-55-2-ascites_cyto-effusion (36-55)_ascites_80'sF_Giemsa_invasion of multiple myeloma-2

cyto-56-CSF_cyto-brain (56-62)_cerebrospinal fluid_76M_Giemsa_adult T-cell leukemia

cyto-57-CSF_cyto-brain (56-62)_cerebrospinal fluid_4M_Giemsa_acute lymphoblastic leukemia L1)

cyto-58-CSF_cyto-brain (56-62)_cerebrospinal fluid_58F_Giemsa_metastatic signet ring cell carcinoma

cyto-59-brain_cyto-brain (56-62)_brain tumor touch_48F_Pap_astrocytoma, round cell type

cyto-60-brain_cyto-brain (56-62)_brain tumor touch_23F_Pap_anaplastic astrocytoma

cyto-61-brain_cyto-brain (56-62)_brain tumor touch_68F_Pap_meningioma

cyto-62-1-brain_cyto-brain (56-62)_brain tumor touch_43F_Pap_metastatic adenocarcinoma-1

cyto-62-2-brain_cyto-brain (56-62)_brain tumor touch_43F_Giemsa_metastatic adenocarcinoma-2

cyto-63-1-LN_cyto-hemato (63-86)_lymph node touch_42M_Pap_Hodgkin's lymphoma-1

cyto-63-2-LN_cyto-hemato (63-86)_lymph node touch_42M_Giemsa_Hodgkin's lymphoma-2

cyto-64-1-LN_cyto-hemato (63-86)_lymph node touch_71M_Pap_Diffuse large B-cell lymphoma-1

cyto-64-2-LN_cyto-hemato (63-86)_lymph node touch_71M_Giemsa_Diffuse large B-cell lymphoma-2

cyto-65-1-LN_cyto-hemato (63-86)_lymph node touch_21F_Pap_Ki-1 lymphoma-1

cyto-65-2-LN_cyto-hemato (63-86)_lymph node touch_21F_Giemsa_Ki-1 lymphoma-1

cyto-66-1-LN_cyto-hemato (63-86)_lymph node touch_22M_Pap_adult T-cell leukemia/lymphoma-1

cyto-66-2-LN_cyto-hemato (63-86)_lymph node touch_22M_Giemsa_adult T-cell leukemia/lymphoma-2

cyto-67-1-ovary_cyto-hemato (63-86)_ovary touch_23F_Pap_Burkitt lymphoma-1

cyto-67-2-ovary_cyto-hemato (63-86)_ovary touch_23F_Giemsa_Burkitt lymphoma-1

cyto-68-1-nose_cyto-hemato (63-86)_nasal mucosa touch_28M_Pap_nasal NK/T-cell lymphoma-1

cyto-68-2-nose_cyto-hemato (63-86)_nasal mucosa touch_28M_Giemsa_nasal NK/T-cell lymphoma-2

cyto-70-BM_cyto-hemato (63-86)_bone marrow_70M_Giemsa_acute monocytic leukemia (M5)

cyto-71-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_target cells

cyto-72-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_tear drop cells

cyto-73-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_acanthocytes

cyto-74-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_spherocytes

cyto-75-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_schistocytes

cyto-76-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_Howell-Jolly bodies

cyto-77-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_Pappenheimer bodies

cyto-78-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_Rouleaux formation

cyto-79-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_leukemic transformation of lymphoma

cyto-80-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_adult T-cell lymphoma

cyto-81-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_chronic lymphocytic leukemia

cyto-82-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_chronic myeloid leukemia

cyto-83-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_acute myeloblastic leukemia (M2)

cyto-84-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_acute promyelocytic leukemia (M3)

cyto-85-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_acute monocytic leukemia (M5)

cyto-86-PB_cyto-hemato (63-86)_peripheral blood_-_Giemsa_acute monocytic leukemia (M5b)

PATHOS TSUTSUMI PROJECT

”Tsutsumi Pathology Library”

Yutaka Tsutsumi, M.D.

course 1
program3. Cytology (general) 86 cases

Tsutsumi Pathology Library
office：Pathos Ysutsumi, a diagnostic clinic (Tsutsumi Byori Shindanka Clinic)
Sankichiato 1551-1,Yawase-cho Inazawa, Aichi 492-8342,Japan

course 1 program3. Cytology (general) 86 cases

course 1
program3. Cytology (general) 86 cases